LEO III Fund has acquired PronoKal Group from Nestlé Health Science to strengthen its position in the growing ketogenic nutrition market.

Target Company Overview

LEO III Fund has successfully acquired PronoKal Group from Nestlé Health Science, marking a significant milestone for the company. As a leading entity in the ketogenic nutrition market, PronoKal is poised to operate as an independent company, enabling it to further solidify its market position. The company's foundation in scientifically-backed, medically supervised nutrition equips it to innovate rapidly and expand its reach on an international scale.

This acquisition will empower PronoKal to enhance its offerings and deliver impactful health solutions that align with the growing demand for ketogenic diets. The focus will be on sustainability and effective nutrition strategies that cater to diverse consumer needs.

Industry Overview

The ketogenic diet sector has seen tremendous growth in recent years, particularly in markets like Spain. Factors contributing to this trend include rising health consciousness among consumers, an increasing prevalence